Disease-modifying drugs for multiple sclerosis and JC virus expression-Reference-Cited by-同舟云学术

Disease-modifying drugs for multiple sclerosis and JC virus expression

Published:2012-05-15 Issue:5 Volume:18 Page:411-415
ISSN:1355-0284
Container-title:Journal of NeuroVirology
language:en
Short-container-title:J. Neurovirol.

Author:

Miller Craig S.,Houff Sidney A.,Hopper Jason,Danaher Robert J.,Gurwell Julie A.,Lin Yushun,Vega Nubia,Berger Joseph R.

Publisher

Springer Science and Business Media LLC

Subject

Virology,Cellular and Molecular Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s13365-012-0107-0.pdf

Reference19 articles.

1. Alvarez-Lafuente R, Garcia-Montojo M et al (2007) Interferon-beta treatment and active replication of the JC virus in relapsing-remitting multiple sclerosis patients. Eur J Neurol 14(2):233–236

2. Berger J, Pall L et al (1992) A pilot study of recombinant alpha 2a interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy (abstract). Neurology 42(Suppl 3):257

3. Berger JR, Miller CS et al (2006) JC virus detection in bodily fluids: clues to transmission. Clin Infect Dis 43(1):e9–e12

4. BiogenIdec (2011) PML incidence in patients receiving TYSABRI. https://medinfo.biogenidec.com/medinfo/secure/pmlresource.do?resource=TYSABRIPMLSafetyUpdate . Accessed 26 Nov 2011

5. Biron CA (1999) Initial and innate responses to viral infections—pattern setting in immunity or disease. Curr Opin Microbiol 2(4):374–381

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic expression of JC virus in urine and its relationship to serostatus;Multiple Sclerosis and Related Disorders;2020-06

2. COVID-19 and MS disease-modifying therapies;Neurology - Neuroimmunology Neuroinflammation;2020-05-15

3. Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies;Neurotherapeutics;2017-09-14

4. Classifying PML risk with disease modifying therapies;Multiple Sclerosis and Related Disorders;2017-02

5. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives;Therapeutic Advances in Neurological Disorders;2015-09-07